tiprankstipranks
Blurbs

Analysts Are Bullish on Top Healthcare Stocks: Nkarta (NKTX), Indaptus Therapeutics (INDP)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Nkarta (NKTXResearch Report) and Indaptus Therapeutics (INDPResearch Report) with bullish sentiments.

Nkarta (NKTX)

H.C. Wainwright analyst Emily Bodnar maintained a Buy rating on Nkarta today and set a price target of $30.00. The company’s shares closed last Friday at $4.60, close to its 52-week low of $3.12.

According to TipRanks.com, Bodnar has 0 stars on 0-5 stars ranking scale with an average return of -9.3% and a 35.2% success rate. Bodnar covers the Healthcare sector, focusing on stocks such as Acrivon Therapeutics, Inc., Gracell Biotechnologies, and Olema Pharmaceuticals.

Nkarta has an analyst consensus of Strong Buy, with a price target consensus of $24.67, implying a 415.0% upside from current levels. In a report released today, Mizuho Securities also maintained a Buy rating on the stock with a $26.00 price target.

See today’s best-performing stocks on TipRanks >>

Indaptus Therapeutics (INDP)

Maxim Group analyst Jason McCarthy maintained a Buy rating on Indaptus Therapeutics yesterday and set a price target of $4.00. The company’s shares closed last Friday at $2.07.

According to TipRanks.com, McCarthy is ranked 0 out of 5 stars with an average return of -28.4% and a 20.5% success rate. McCarthy covers the Healthcare sector, focusing on stocks such as Genenta Science SpA Sponsored ADR, Reviva Pharmaceuticals Holdings, and Brainstorm Cell Therapeutics.

Indaptus Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $8.00, representing a 272.1% upside. In a report issued on May 4, H.C. Wainwright also reiterated a Buy rating on the stock with a $12.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on NKTX:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles